Intellectual Property
![](https://uschamber.imgix.net/https%3A%2F%2Fwww.uschamber.com%2Fassets%2Fimages%2FIP.topicpage.jpg?auto=compress%2Cformat&fit=clip&fm=jpg&q=10&w=100&s=a382ae370704b74704f18e4fc0a208bf)
Every innovation that improves lives, advances society, and drives our economy starts with an idea. Strong intellectual property rights—including patents, trademarks, and copyrights—protect and incentivize those ideas. When inventors, researchers, engineers, artists, and entrepreneurs have legal certainty that their work will be protected and rewarded, they can keep the transformative ideas coming. Intellectual property protections also shield consumers from dangerous fake and counterfeit goods, giving people assurances that products—from life-saving medicines to toys—are safe and authentic.
Latest
![](https://uschamber.imgix.net/https%3A%2F%2Fwww.uschamber.com%2Fassets%2Fimages%2F2024_International_IPIndex.jpg?auto=compress%2Cformat&fit=clip&fm=jpg&q=10&w=100&s=cf7a62611e89c6b289c2041fb15510b0)
2024 International IP Index
The 12th edition of the U.S. Chamber’s International IP Index is a comprehensive assessment of the world’s intellectual property frameworks. It shows the power of smart policies to foster innovation, creativity, and economic growth and unlock opportunity.
Learn More
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber’s Global Innovation Policy Center champions innovation and creativity through intellectual property standards so businesses can save lives, solve problems, create jobs, advance growth, and enhance society. Our work to protect strong intellectual property rights begins in Washington, D.C., and extends to countries across the globe.
Events
- InfrastructureGlobal Aerospace Summit 2024Tuesday, September 10 - Wednesday, September 1108:00 AM EDT - 05:00 PM EDTLearn More
- Employment PolicyReimagining Futures: Second Chance Employment ForumWednesday, September 1802:00 PM EDT - 07:00 PM EDTLearn More
- Corporate Social ResponsibilityBusiness Solves: Strengthening Communities, Today and TomorrowTuesday, October 29 - Wednesday, October 3009:00 AM EDT - 05:00 PM EDTLearn More
Latest Content
More than a year into the COVID-19 pandemic the rollout of vaccines has taken center stage, but the rapid tests that have been developed to determine who is infected remain critical to reducing the spread and beating the pandemic.
Hearing on “Building Back the U.S. Research Enterprise: COVID Impacts and Recovery” Testimony of Tom Quaadman, Executive Vice President, U.S. Chamber of Commerce, before the U.S. House of Representatives Committee on Science, Space, and Technology.
Stanley Black & Decker is thinking outside the box and ensuring the latest innovations are being used to fight COVID-19.
Everything you need to know to shop smart for Sunday's Super Bowl.
Not even a pandemic can diminish the importance of the arts and entertainment industries – in fact, Americans have doubled down on their cultural consumption across the board.
WASHINGTON, D.C. - “On Thursday, December 31, 2020, we unexpectedly lost a dear friend and accomplished colleague, Richard Bates. We extend our deepest sympathy to his family, the entire Disney team, and all those who knew and loved him.
Protect Lawful Streaming Act, Case Act, and Trademark Modernization Act are a trifecta of wins for America’s innovators, creators, and consumers.WASHINGTON, D.C. — David Hirschmann, President & CEO of the U.S. Chamber of Commerce’s Global Innovation Policy Center, released the following statement in response to congress passing bipartisan legislation to protect intellectual property.
On December 14 the first shots of the vaccine were given to the American public.
WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine:
3rd Annual IP Dialogue virtually convenes academic, industry, and public sector IP experts